7.22-7.28 | 临床研究顶刊快报
文摘
教育
2024-07-29 10:08
中国香港
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
1. Loomba R, Hartman ML, Lawitz EJ, Vuppalanchi R, Boursier J, Bugianesi E, et al. Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis. New England Journal of Medicine. 2024;391(4):299-310.2. Sanyal AJ, Bedossa P, Fraessdorf M, Neff GW, Lawitz E, Bugianesi E, et al. A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis. New England Journal of Medicine. 2024;391(4):311-9.3. Litzow MR, Sun Z, Mattison RJ, Paietta EM, Roberts KG, Zhang Y, et al. Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults. New England Journal of Medicine. 2024;391(4):320-33.4. Fraissenon A, Bayard C, Morin G, Benichi S, Hoguin C, Protic S, et al. Sotorasib for Vascular Malformations Associated with KRAS G12C Mutation. New England Journal of Medicine. 2024;391(4):334-42.5. Garg AX, Arnold JB, Cuerden MS, Dipchand C, Feldman LS, Gill JS, et al. Hypertension and Kidney Function After Living Kidney Donation. JAMA. 2024;332(4):287-99.6. Gray BM, Vandergrift JL, Stevens JP, Lipner RS, McDonald FS, Landon BE. Associations of Internal Medicine Residency Milestone Ratings and Certification Examination Scores With Patient Outcomes. JAMA. 2024;332(4):300-9.7. Champion ML, Blanchard CT, Lu MY, Shea AE, Lively AI, Jenkins JM, et al. A More Selective vs a Standard Risk-Stratified, Heparin-Based, Obstetric Thromboprophylaxis Protocol. JAMA. 2024;332(4):310-7.8. Borchmann P, Ferdinandus J, Schneider G, Moccia A, Greil R, Hertzberg M, et al. Assessing the efficacy and tolerability of PET-guided BrECADD versus eBEACOPP in advanced-stage, classical Hodgkin lymphoma (HD21): a randomised, multicentre, parallel, open-label, phase 3 trial. The Lancet. 2024;404(10450):341-52.9. Frank MJ, Baird JH, Kramer AM, Srinagesh HK, Patel S, Brown AK, et al. CD22-directed CAR T-cell therapy for large B-cell lymphomas progressing after CD19-directed CAR T-cell therapy: a dose-finding phase 1 study. The Lancet. 2024;404(10450):353-63.10. Gendreau RM, McCracken LM, Williams DA, Luciano JV, Dai Y, Vega N, et al. Self-guided digital behavioural therapy versus active control for fibromyalgia (PROSPER-FM): a phase 3, multicentre, randomised controlled trial. The Lancet. 2024;404(10450):364-74.11. Camacho EM, Penner LS, Taylor A, Guthrie B, Avery AJ, Ashcroft DM, et al. Estimating the economic effect of harm associated with high risk prescribing of oral non-steroidal anti-inflammatory drugs in England: population based cohort and economic modelling study. BMJ. 2024;386:e077880.12. Solberg RB, Fretheim A, Elgersma IH, Fagernes M, Iversen BG, Hemkens LG, et al. Personal protective effect of wearing surgical face masks in public spaces on self-reported respiratory symptoms in adults: pragmatic randomised superiority trial. BMJ. 2024;386:e078918. 13. Song J, Wang X, Wang B, Ge Y, Bi L, Jing F, et al. Learning implementation of a guideline based decision support system to improve hypertension treatment in primary care in China: pragmatic cluster randomised controlled trial. BMJ. 2024;386:e079143.14. Ko Y-C, Lin H-Y, Huang EP-C, Lee A-F, Hsieh M-J, Yang C-W, et al. Intraosseous versus intravenous vascular access in upper extremity among adults with out-of-hospital cardiac arrest: cluster randomised clinical trial (VICTOR trial). BMJ. 2024;386:e079878.部分文字参考新英格兰医学前沿。
